Digilab

A global leader in molecular spectroscopy systems for over 40 years, Digilab provides innovative products and services for the life sciences research and in-vitro diagnostics markets including pharmaceutical and biotech industries as well as universities and governments. Digilab's primary focus is on sample preparation, bioinformatics, and detection/analysis tools enabling solutions for research and development featuring molecular spectroscopy methods. Digilab acquired SpectraCode in West Lafayette Indiana, a technology leader in Raman Spectroscopy and developer of systems/solutions for portable "point of need" molecular spectroscopy identification. Digilab concluded an exclusive OEM Distribution Agreement with Boehringer Ingelheim Microparts under which it commercializes Boehringer Ingelheim proprietary MicroSystems Technology (MST) Microspectrometers. Digilab and Boehringer Ingelheim also have a cooperation to bring point of need molecular spectroscopy devices to the marketplace. Digilab also acquired BioVisioN GmbH, now Digilab Peptidomics(R). Digilab Peptidomics has developed and commercializes internationally patented Peptidomics products and services. Digilab works with companies such as AstraZeneca, Boehringer Ingelheim, Merck & Co, Novartis, Novo Nordisk, Roche Diagnostics, Abbott Laboratories, and Solvay Pharmaceuticals to address their needs for novel peptide biomarkers and bioactive peptides for targeted therapeutics.